Eric G Stefanich (Eric Stefanich)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 2

Top Topics

Endoplasmic Reticulum Stress

Combination Therapy

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, Michael J Pishvaian, Yung-Jue Bang, Michael S Gordon, Ahmad Awada, D Ross Camidge, F Stephen Hodi, Grant A McArthur, Wilson H Miller, Andres Cervantes, Laura Q M Chow, Alexander M Lesokhin, Annemie Rutten, Mario Sznol, Deepali Rishipathak, Shang-Chiung Chen, Eric G Stefanich, Tony Pourmohamad, Maria Anderson, Jeong Kim, Mahrukh Huseni, Ina Rhee, Lillian L Siu
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (16) (2022)
Donna W Lee, Shelly Zhong, Rama Pai, Julie Rae, Siddharth Sukumaran, Eric G Stefanich, Jeff Lutman, Estelle Doudement, Xiaoting Wang, Brandon J Harder, Annemarie N Lekkerkerker, Ann Herman, Wenjun Ouyang, Dimitry M Danilenko
Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatability. Pharmacology research & perspectives 6 (6) (2018)